Cargando…
High HPgV replication is associated with improved surrogate markers of HIV progression
BACKGROUND: Human Pegivirus (HPgV) may have a beneficial effect on HIV disease progression in co-infected patients; however, the virologic characteristics of this infection are not well defined. In this study, we determined HPgV viremia prevalence in Mexico and provide new insights to understand HPg...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598987/ https://www.ncbi.nlm.nih.gov/pubmed/28910347 http://dx.doi.org/10.1371/journal.pone.0184494 |
_version_ | 1783264015031468032 |
---|---|
author | Horemheb-Rubio, Gibran Ramos-Cervantes, Pilar Arroyo-Figueroa, Hugo Ávila-Ríos, Santiago García-Morales, Claudia Reyes-Terán, Gustavo Escobedo, Galileo Estrada, Gloria García-Iglesias, Trinidad Muñoz-Saucedo, Nayeli Kershenobich, David Ostrosky-Wegman, Patricia Ruiz-Palacios, Guillermo M. |
author_facet | Horemheb-Rubio, Gibran Ramos-Cervantes, Pilar Arroyo-Figueroa, Hugo Ávila-Ríos, Santiago García-Morales, Claudia Reyes-Terán, Gustavo Escobedo, Galileo Estrada, Gloria García-Iglesias, Trinidad Muñoz-Saucedo, Nayeli Kershenobich, David Ostrosky-Wegman, Patricia Ruiz-Palacios, Guillermo M. |
author_sort | Horemheb-Rubio, Gibran |
collection | PubMed |
description | BACKGROUND: Human Pegivirus (HPgV) may have a beneficial effect on HIV disease progression in co-infected patients; however, the virologic characteristics of this infection are not well defined. In this study, we determined HPgV viremia prevalence in Mexico and provide new insights to understand HPgV infection and HPgV/HIV co-infection. METHODS: We analyzed and quantified 7,890 serum samples for HPgV viremia by One-Step RT-Real-Time PCR, 6,484 from healthy blood donors and 1,406 from HIV-infected patients. Data on HIV progression were obtained from patients’ records. HPgV genotyping was performed in 445 samples by nested PCR of the 5’URT region. Finite Mixture Models were used to identify clustering patterns of HPgV viremia in blood donors and co-infected antiretroviral (ART)-naïve patients. RESULTS: HPgV was detected in 2.98% of blood donors and 33% of HIV patients, with a wide range of viral loads. The most prevalent genotypes were 3 (58.6%)and 2 (33.7%). HPgV viral loads from healthy blood donors and HPgV/HIV+ ART-naïve co-infected patients were clustered into two component distributions, low and high, with a cut-off point of 5.07log(10) and 5.06log(10), respectively. High HPgV viremia was associated with improved surrogate markers of HIV infection, independent of the estimated duration of HIV infection or HIV treatment. CONCLUSIONS: HPgV prevalence in Mexico was similar to that reported for other countries. The prevalent genotypes could be related to Mexico’s geographic location and ethnicity, since genotype 2 is frequent in the United States and Europe and genotype 3 in Asia and Amerindian populations. HPgV viral load demonstrated two patterns of replication, low and high. The more pronounced beneficial response observed in co-infected patients with high HPgV viremia may explain discrepancies found between other studies. Mechanisms explaining high and low HPgV replication should be explored to determine whether the persistently elevated replication depends on host or viral factors. |
format | Online Article Text |
id | pubmed-5598987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-55989872017-09-22 High HPgV replication is associated with improved surrogate markers of HIV progression Horemheb-Rubio, Gibran Ramos-Cervantes, Pilar Arroyo-Figueroa, Hugo Ávila-Ríos, Santiago García-Morales, Claudia Reyes-Terán, Gustavo Escobedo, Galileo Estrada, Gloria García-Iglesias, Trinidad Muñoz-Saucedo, Nayeli Kershenobich, David Ostrosky-Wegman, Patricia Ruiz-Palacios, Guillermo M. PLoS One Research Article BACKGROUND: Human Pegivirus (HPgV) may have a beneficial effect on HIV disease progression in co-infected patients; however, the virologic characteristics of this infection are not well defined. In this study, we determined HPgV viremia prevalence in Mexico and provide new insights to understand HPgV infection and HPgV/HIV co-infection. METHODS: We analyzed and quantified 7,890 serum samples for HPgV viremia by One-Step RT-Real-Time PCR, 6,484 from healthy blood donors and 1,406 from HIV-infected patients. Data on HIV progression were obtained from patients’ records. HPgV genotyping was performed in 445 samples by nested PCR of the 5’URT region. Finite Mixture Models were used to identify clustering patterns of HPgV viremia in blood donors and co-infected antiretroviral (ART)-naïve patients. RESULTS: HPgV was detected in 2.98% of blood donors and 33% of HIV patients, with a wide range of viral loads. The most prevalent genotypes were 3 (58.6%)and 2 (33.7%). HPgV viral loads from healthy blood donors and HPgV/HIV+ ART-naïve co-infected patients were clustered into two component distributions, low and high, with a cut-off point of 5.07log(10) and 5.06log(10), respectively. High HPgV viremia was associated with improved surrogate markers of HIV infection, independent of the estimated duration of HIV infection or HIV treatment. CONCLUSIONS: HPgV prevalence in Mexico was similar to that reported for other countries. The prevalent genotypes could be related to Mexico’s geographic location and ethnicity, since genotype 2 is frequent in the United States and Europe and genotype 3 in Asia and Amerindian populations. HPgV viral load demonstrated two patterns of replication, low and high. The more pronounced beneficial response observed in co-infected patients with high HPgV viremia may explain discrepancies found between other studies. Mechanisms explaining high and low HPgV replication should be explored to determine whether the persistently elevated replication depends on host or viral factors. Public Library of Science 2017-09-14 /pmc/articles/PMC5598987/ /pubmed/28910347 http://dx.doi.org/10.1371/journal.pone.0184494 Text en © 2017 Horemheb-Rubio et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Horemheb-Rubio, Gibran Ramos-Cervantes, Pilar Arroyo-Figueroa, Hugo Ávila-Ríos, Santiago García-Morales, Claudia Reyes-Terán, Gustavo Escobedo, Galileo Estrada, Gloria García-Iglesias, Trinidad Muñoz-Saucedo, Nayeli Kershenobich, David Ostrosky-Wegman, Patricia Ruiz-Palacios, Guillermo M. High HPgV replication is associated with improved surrogate markers of HIV progression |
title | High HPgV replication is associated with improved surrogate markers of HIV progression |
title_full | High HPgV replication is associated with improved surrogate markers of HIV progression |
title_fullStr | High HPgV replication is associated with improved surrogate markers of HIV progression |
title_full_unstemmed | High HPgV replication is associated with improved surrogate markers of HIV progression |
title_short | High HPgV replication is associated with improved surrogate markers of HIV progression |
title_sort | high hpgv replication is associated with improved surrogate markers of hiv progression |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598987/ https://www.ncbi.nlm.nih.gov/pubmed/28910347 http://dx.doi.org/10.1371/journal.pone.0184494 |
work_keys_str_mv | AT horemhebrubiogibran highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT ramoscervantespilar highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT arroyofigueroahugo highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT avilariossantiago highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT garciamoralesclaudia highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT reyesterangustavo highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT escobedogalileo highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT estradagloria highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT garciaiglesiastrinidad highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT munozsaucedonayeli highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT kershenobichdavid highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT ostroskywegmanpatricia highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression AT ruizpalaciosguillermom highhpgvreplicationisassociatedwithimprovedsurrogatemarkersofhivprogression |